Sensient Technologies Corp manufactures and markets natural and synthetic colors, flavors, and other specialty ingredients... Show more
Sensient Technologies Corporation is a global manufacturer and marketer of colors, flavors, and other specialty ingredients serving the food and beverage, pharmaceutical, nutraceutical, and personal care industries. Its competitive edge rests on technical differentiation, a vertically integrated botanical supply chain, and deep research and development (R&D) capabilities that competitors find difficult to replicate quickly.
The Color Group is the company's structural growth engine. In 2025, the segment grew local-currency revenue by 7.4% and operating profit by 16.9%, expanding its adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) margin to 23.7%. This reflects favorable mix shift toward complex, higher-margin natural color systems rather than simple volume growth. Management is targeting a long-term $1 billion sales goal in natural colors, supported by stepped-up R&D, capacity expansion, and proprietary product lines such as BERBEET and Advanced Emulsion Technology systems.
By contrast, the Flavors & Extracts and Asia Pacific groups face near-term headwinds from weather disruptions, crop cost inflation, and tariff-related supply chain friction. The medium-term positioning story therefore hinges on whether Color Group momentum and operating leverage can outpace the drag from these smaller, more cyclical segments.
The next quarterly earnings release, expected around late October 2026, will be a pivotal checkpoint for investors. Consensus estimates point to adjusted earnings per share (EPS) of roughly $1.09 for the quarter, and the market will scrutinize whether natural color conversion revenue is tracking toward the company's stated expectation of a meaningful ramp in the third and fourth quarters of 2026.
Regulatory milestones remain the dominant structural catalyst. The federal prohibition on Red 3, effective January 2027, followed by state-level bans beginning in 2028, is already prompting major food and beverage companies to reformulate products. Because natural colorants can command a revenue multiple of roughly ten-to-one relative to the synthetic colors they replace, even a modest conversion of Sensient's estimated $100 million synthetic revenue base represents a substantial top-line opportunity.
Analyst activity reflects growing confidence, though it is not unanimous. UBS has raised its price target to $157 from $155 while maintaining a Buy rating, and earlier lifted it from $143. Baird raised its target to $140 from $125 with an Outperform rating. Redburn Atlantic initiated coverage with a Neutral rating and a $125 target, citing competitive and execution considerations. The consensus 12-month price target sits near $140, versus a share price in the mid-$130s, implying limited near-term upside until conversion revenue becomes more visible.
Sensient's trajectory is tightly linked to the broader clean-label movement, as regulators and large consumer brands accelerate the removal of synthetic dyes. This secular tailwind is partly insulated from discretionary spending cycles because reformulation is often compliance-driven rather than demand-driven.
Macro factors still matter. Interest rates directly influence the cost of the company's rising debt load, and management has signaled that debt and interest expense will increase in 2026 as capital is deployed ahead of the natural color revenue ramp. Inflation and crop-cost volatility in agricultural ingredients can compress margins, while tariffs and logistics disruptions continue to pressure the Asia Pacific segment. Sustained consumer packaged goods volume softness could also slow the pace of customer reformulation projects, even if the regulatory deadline itself does not move.
For traders seeking a data-driven view of near-term direction, Tickeron's Trend Prediction Engine offers an AI-powered forecasting tool that helps identify whether a stock, ETF (exchange-traded fund), or other asset may move bullish, bearish, or sideways over the next week or month. The platform is designed to help users spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a wide range of tradable instruments. It also includes searchable prediction categories, historical context, and alert-oriented functionality to support timely decision-making. Explore the Trend Prediction Engine to see how artificial intelligence can complement your own analysis of Sensient and the broader market.
Management's 2026 guidance calls for mid-single-digit to double-digit local-currency revenue and adjusted EBITDA growth, with GAAP diluted EPS between $3.60 and $3.80. The investment thesis centers on a back-half acceleration: as capacity comes online and customer conversion deadlines approach, operating leverage is expected to improve meaningfully into late 2026 and 2027.
Several long-term themes will shape the company beyond 2026. The natural color conversion cycle, extending toward 2028, provides a multi-year growth runway and supports margin durability through favorable mix. Cost structure evolution will be critical, as heavy capital expenditures and expanded technical staffing temporarily suppress profit leverage before scale benefits accrue. Competitive threats are rising as rivals also build natural color capacity, making R&D leadership and supply-chain reliability the key differentiators.
Capital allocation priorities will also matter. With no share repurchases planned during the investment surge, investors will watch whether leverage stays below management's stated target of roughly 3x net debt to adjusted EBITDA. Consensus expectations for revenue growth in the mid-single digits, faster than the industry average, suggest analysts broadly accept the growth acceleration narrative, but sustained margin delivery and conversion execution will determine whether sentiment strengthens further.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MSST | 28.67 | 1.25 | +4.57% |
| YieldMax MSTR Performance & Distribution Target 25 ETF (MSST) | |||
| STXG | 55.66 | 0.80 | +1.47% |
| Strive 1000 Growth ETF (STXG) | |||
| AAEQ | 54.62 | 0.77 | +1.43% |
| Alpha Architect US Equity 2 ETF (AAEQ) | |||
| BSCS | 20.22 | 0.02 | +0.10% |
| Invesco BulletShares 2028 Corporate Bond ETF (BSCS) | |||
| MARS | 21.60 | -0.65 | -2.92% |
| Roundhill Space & Technology ETF (MARS) | |||
A.I.dvisor indicates that over the last year, SXT has been loosely correlated with ASIX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SXT jumps, then ASIX could also see price increases.
| Ticker / NAME | Correlation To SXT | 1D Price Change % | ||
|---|---|---|---|---|
| SXT | 100% | +7.66% | ||
| ASIX - SXT | 43% Loosely correlated | -0.39% | ||
| OLN - SXT | 41% Loosely correlated | +3.14% | ||
| HUN - SXT | 37% Loosely correlated | +4.19% | ||
| RPC - SXT | 36% Loosely correlated | +2.98% | ||
| IOSP - SXT | 34% Loosely correlated | -18.72% | ||
More | ||||
a manufacturer of flavors, fragrances and colors
Industry ChemicalsSpecialty
The 10-day moving average for SXT crossed bearishly below the 50-day moving average on October 30, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 70%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 29 of 57 cases where SXT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 51%.
The Momentum Indicator moved below the 0 level on October 27, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SXT as a result. In 43 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 49%.
The Moving Average Convergence Divergence Histogram (MACD) for SXT turned negative on October 26, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 23 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 50%.
SXT moved below its 50-day moving average on October 28, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SXT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where SXT's RSI Oscillator exited the oversold zone, 18 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 58%.
Following a +0.67% 3-day Advance, the price is estimated to grow further. Considering data from situations where SXT advanced for three days, in 175 of 275 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.
SXT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 118 of 181 cases where SXT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 65%.
The Tickeron PE Growth Rating for this company is 32 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 46 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock slightly better than average.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating fairly steady price growth. SXT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 61 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 78 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.250) is normal, around the industry mean (2.450). P/E Ratio (33.732) is within average values for comparable stocks, (-17.964). Projected Growth (PEG Ratio) (1.735) is also within normal values, averaging (1.548). Dividend Yield (0.013) settles around the average of (0.040) among similar stocks. P/S Ratio (3.215) is also within normal values, averaging (48.960).